Products

Human papillomavirus cDNA and Antigen

Cat#

Product Name

Swiss Prot#

Size

Price (US$)

Order

PN0936

Recombinant Protein-Human papillomavirus Late minor capsid protein L2 (a.a.31 to 461)

Q80972

100 µg

1195

Order

PN0937

Recombinant Protein-Human papillomavirus-81 Y protein (a.a.11 to 107)

Q705E0

100 µg

1195

Order

PN0938

Recombinant Protein-Human papillomavirus-81 X protein (a.a.41 to 100)

Q705E1

100 µg

1195

Order

PN0939

Recombinant Protein-Human papillomavirus type 16 L1 (a.a.51 to 525)

B1PM96

100 µg

1195

Order

PN0940

Recombinant Protein-Human papillomavirus type 16 E6 (a.a.21 to 158)

B9UPB5

100 µg

1195

Order

PN0941

Recombinant Protein-Human papillomavirus type 16 E1 (a.a.51 to 450)

B9UPB7

100 µg

1195

Order

PN0942

Recombinant Protein-Human papillomavirus type 16 E2 (a.a.21 to 365)

B9UPB8

100 µg

1195

Order

PN0943

Recombinant Protein-Human papillomavirus type 16 E7 protein (a.a.1 to 98)

Q547B8

100 µg

1195

Order

PN0944

Recombinant Protein-Human papillomavirus type 59 ORF putative E6 protein (a.a.21 to 160)

Q81964

100 µg

1195

Order

PN0945

Recombinant Protein-Human papillomavirus type 59 E7 (a.a.21 to 107)

Q81965

100 µg

1195

Order

PN0946

Recombinant Protein-Human papillomavirus type 59 ORF putative E2 protein (a.a.21 to 370)

Q81967

100 µg

1195

Order

PN0947

Recombinant Protein-Human papillomavirus type 59 L1 protein (a.a.51 to 508)

Q81971

100 µg

1195

Order

PN0948

Recombinant Protein-Human papillomavirus type 92 L1 (a.a.51 to 512)

Q8B5B0

100 µg

1195

Order

PN0949

Recombinant Protein-Human papillomavirus type 92 E2 (a.a.51 to 477)

Q8B5B3

100 µg

1195

Order

PN0950

Recombinant Protein-Human papillomavirus type 92 E7 (a.a.18 to 91)

Q8B5B5

100 µg

1195

Order

PN0951

Recombinant Protein-Human papillomavirus type 92 E6 (a.a.18 to 138)

Q8B5B6

100 µg

1195

Order

RPN0936

cDNA-Human papillomavirus Late minor capsid protein L2 (a.a.31 to 461)

Q80972

2 µg

2150

Order

RPN0937

cDNA-Human papillomavirus-81 Y protein (a.a.11 to 107)

Q705E0

2 µg

800

Order

RPN0938

cDNA-Human papillomavirus-81 X protein (a.a.41 to 100)

Q705E1

2 µg

800

Order

RPN0939

cDNA-Human papillomavirus type 16 L1 (a.a.51 to 525)

B1PM96

2 µg

2370

Order

RPN0940

cDNA-Human papillomavirus type 16 E6 (a.a.21 to 158)

B9UPB5

2 µg

800

Order

RPN0941

cDNA-Human papillomavirus type 16 E1 (a.a.51 to 450)

B9UPB7

2 µg

1995

Order

RPN0942

cDNA-Human papillomavirus type 16 E2 (a.a.21 to 365)

B9UPB8

2 µg

1720

Order

RPN0943

cDNA-Human papillomavirus type 16 E7 protein (a.a.1 to 98)

Q547B8

2 µg

800

Order

RPN0944

cDNA-Human papillomavirus type 59 ORF putative E6 protein (a.a.21 to 160)

Q81964

2 µg

800

Order

RPN0945

cDNA-Human papillomavirus type 59 E7 (a.a.21 to 107)

Q81965

2 µg

800

Order

RPN0946

cDNA-Human papillomavirus type 59 ORF putative E2 protein (a.a.21 to 370)

Q81967

2 µg

1745

Order

RPN0947

cDNA-Human papillomavirus type 59 L1 protein (a.a.51 to 508)

Q81971

2 µg

2285

Order

RPN0948

cDNA-Human papillomavirus type 92 L1 (a.a.51 to 512)

Q8B5B0

2 µg

2305

Order

RPN0949

cDNA-Human papillomavirus type 92 E2 (a.a.51 to 477)

Q8B5B3

2 µg

2130

Order

RPN0950

cDNA-Human papillomavirus type 92 E7 (a.a.18 to 91)

Q8B5B5

2 µg

800

Order

RPN0951

cDNA-Human papillomavirus type 92 E6 (a.a.18 to 138)

Q8B5B6

2 µg

800

Order

Human papillomavirus cDNA and recombinant antigen

  • Codon-optimized cDNA is cloned into E. coli expression vector with 6x His-tag at N-terminus and ready-to-use for recombinant protein production.
  • Recombinant protein applications: Western Blot may be used for other applications determined by the user.
  • Protein Purity: >90%, as determined by SDS-PAGE under reducing conditions.
  • Protein Activity: N/A
  • Protein Tag:  Contains A 6x histidine tag at N-terminus.
  • Protein Formulation: Liquid
  • Source: Produced from E. coli

Human papillomavirus (HPV) is a common sexually transmitted virus that can cause various types of cancer, including cervical, anal, and oropharyngeal cancer. The virus is composed of several proteins, including Late minor capsid protein L2, 81(Y and X) protein, L1, E1, E2, E6, and E7.

Late minor capsid protein L2 is a structural protein that is involved in the assembly of the virus particle. It plays an important role in the entry of HPV into host cells.

81(Y and X) protein is a protein that is expressed during the early phase of HPV infection. It is involved in the modulation of cellular gene expression and has been linked to the development of cancer.

Type 16 HPV is the most common high-risk type of HPV and is associated with the development of cervical cancer. The virus is composed of several proteins, including L1, E1, E2, E6, and E7. L1 is the major capsid protein of the virus, while E1 and E2 are involved in viral DNA replication. E6 and E7 are oncoproteins that have been linked to the development of cancer.

Type 59 HPV is a low-risk type of HPV that is associated with genital warts. The virus is composed of several proteins, including ORF putative (E6 and E2) protein, E7, and L1.

Type 92 HPV is another low-risk type of HPV that is associated with genital warts. The virus is composed of several proteins, including L1, E2, E6, and E7.

Understanding the structure and function of these proteins is important for the development of effective HPV vaccines and therapeutics. Ongoing research on these proteins and other components of the HPV virus will continue to provide insights into the biology of the virus and potential targets for therapeutic intervention.

The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E.coli expression Vector), which are ready for production of the recombinant proteins.